Ian Malcolm Gould
#156,288
Most Influential Person Now
Ian Malcolm Gould's AcademicInfluence.com Rankings
Ian Malcolm Gouldbiology Degrees
Biology
#12061
World Rank
#15511
Historical Rank
Biotechnology
#205
World Rank
#207
Historical Rank
Microbiology
#706
World Rank
#780
Historical Rank
Neuroscience
#2007
World Rank
#2063
Historical Rank
Download Badge
Biology
Ian Malcolm Gould's Degrees
- PhD Microbiology University of California, Berkeley
- Masters Biotechnology Stanford University
Why Is Ian Malcolm Gould Influential?
(Suggest an Edit or Addition)Ian Malcolm Gould's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Antibiotic resistance—the need for global solutions (2013) (3086)
- Interventions to improve antibiotic prescribing practices for hospital inpatients. (2017) (1218)
- A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic (2013) (420)
- Interventions to improve antibiotic prescribing practices for hospital inpatients. (2017) (348)
- Interventions to improve antibiotic prescribing practices for hospital inpatients. (2013) (344)
- New antibiotic agents in the pipeline and how they can help overcome microbial resistance (2013) (314)
- New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance. (2013) (295)
- Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2005: an 8.5-Year Analysis of Susceptibilities of Candida Species and Other Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing (2007) (294)
- A review of the role of antibiotic policies in the control of antibiotic resistance. (1999) (255)
- The post-antibiotic effect. (1993) (223)
- An international cross-sectional survey of antimicrobial stewardship programmes in hospitals. (2014) (212)
- Antimicrobial Drug Use and Methicillin-resistant Staphylococcus aureus, Aberdeen, 1996–2000 (2004) (198)
- Costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control. (2006) (175)
- Extended spectrum beta-lactamases. (1998) (166)
- Antibiotic resistance: the perfect storm. (2009) (166)
- The clinical significance of methicillin-resistant Staphylococcus aureus. (2005) (151)
- Waterborne outbreak of Escherichia coli 0157 (1991) (129)
- Systematic Review of Antimicrobial Drug Prescribing in Hospitals (2006) (127)
- Comparison of methods for assessing synergic antibiotic interactions. (2000) (115)
- Effects of national antibiotic stewardship and infection control strategies on hospital-associated and community-associated meticillin-resistant Staphylococcus aureus infections across a region of Scotland: a non-linear time-series study. (2015) (111)
- Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals. (2007) (104)
- An outbreak of multiply-resistant Klebsiella pneumoniae in the Grampian region of Scotland. (1996) (104)
- Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis. (2017) (103)
- Clinical relevance of increasing glycopeptide MICs against Staphylococcus aureus. (2008) (94)
- Daptomycin: the role of high-dose and combination therapy for Gram-positive infections. (2013) (89)
- Detection, treatment, and prevention of carbapenemase-producing Enterobacteriaceae: Recommendations from an International Working Group (2013) (88)
- The epidemiology of antibiotic resistance. (2008) (82)
- Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program. (2010) (82)
- Management of serious meticillin-resistant Staphylococcus aureus infections: what are the limits? (2011) (75)
- Antibiotic stewardship: overcoming implementation barriers (2011) (75)
- Costs of healthcare-associated methicillin-resistant Staphylococcus aureus and its control. (2010) (74)
- Trends in Staphylococcus aureus bacteraemia and impacts of infection control practices including universal MRSA admission screening in a hospital in Scotland, 2006–2010: retrospective cohort study and time-series intervention analysis (2012) (74)
- Protein binding and serum bactericidal activities of vancomycin and teicoplanin (1995) (71)
- Topical antimicrobials in combination with admission screening and barrier precautions to control endemic methicillin-resistant Staphylococcus aureus in an Intensive Care Unit. (2007) (70)
- Antibiotic policies and control of resistance (2002) (68)
- Impact of infection control interventions and antibiotic use on hospital MRSA: a multivariate interrupted time-series analysis. (2007) (67)
- Report of the Consensus Conference on Antibiotic Resistance; Prevention and Control (ARPAC). (2005) (66)
- The effect of intravenous-to-oral switch guidelines on the use of parenteral antimicrobials in medical wards. (1998) (64)
- Trends in hospital antibiotic prescribing after introduction of an antibiotic policy. (1996) (62)
- Turning the tide or riding the waves? Impacts of antibiotic stewardship and infection control on MRSA strain dynamics in a Scottish region over 16 years: non-linear time series analysis (2015) (61)
- Antibiotic use in Dutch hospitals 1991-1996. (2000) (61)
- Is Vancomycin MIC “Creep” Method Dependent? Analysis of Methicillin-Resistant Staphylococcus aureus Susceptibility Trends in Blood Isolates from North East Scotland from 2006 to 2010 (2011) (61)
- Nasal Swab Screening for Methicillin-Resistant Staphylococcus aureus—How Well Does It Perform? A Cross-Sectional Study (2012) (60)
- Antibiotic policies to control hospital-acquired infection. (2008) (59)
- New Drugs for Multidrug-Resistant Gram-Negative Organisms: Time for Stewardship (2019) (55)
- Universal screening for meticillin-resistant Staphylococcus aureus: interim results from the NHS Scotland pathfinder project. (2010) (55)
- Clinical consensus conference: survey on Gram-positive bloodstream infections with a focus on Staphylococcus aureus. (2009) (54)
- Antibiotic stewardship and consumption: findings from a pan-European hospital study. (2009) (54)
- Treatment of bacteraemia: meticillin-resistant Staphylococcus aureus (MRSA) to vancomycin-resistant S. aureus (VRSA). (2013) (53)
- Future trends in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection: An in-depth review of newer antibiotics active against an enduring pathogen. (2017) (52)
- Alexander Gordon, puerperal sepsis, and modern theories of infection control--Semmelweis in perspective. (2010) (51)
- Antibiotic heterogeneity: from concept to practice (2010) (51)
- Recently approved antibacterials for methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive pathogens: the shock of the new. (2017) (50)
- A nonlinear time-series analysis approach to identify thresholds in associations between population antibiotic use and rates of resistance (2019) (50)
- Antibiotic resistance in Staphylococcus aureus and its relevance in therapy (2005) (50)
- Combination Antimicrobial Susceptibility Testing of Multidrug-Resistant Stenotrophomonas maltophilia from Cystic Fibrosis Patients (2012) (49)
- Antibiotic exposure as a risk factor for emergence of resistance: the influence of concentration (2002) (49)
- Cost effectiveness of prophylaxis in dental practice to prevent infective endocarditis. (1993) (49)
- Current and future treatment options for community-associated MRSA infection (2018) (48)
- Status of infection control policies and organisation in European hospitals, 2001: the ARPAC study. (2006) (48)
- Universal screening for meticillin-resistant Staphylococcus aureus in acute care: risk factors and outcome from a multicentre study. (2012) (47)
- The laboratory diagnosis of peritonitis during continuous ambulatory peritoneal dialysis. (1986) (47)
- The response of Enterobacteriaceae to beta-lactam antibiotics--'round forms, filaments and the root of all evil'. (1997) (46)
- Combination testing of multidrug-resistant cystic fibrosis isolates of Pseudomonas aeruginosa: use of a new parameter, the susceptible breakpoint index. (2010) (46)
- Prevention of late haematogenous infection in major prosthetic joints. (1989) (46)
- Protected environments allow parallel evolution of a bacterial pathogen in a patient subjected to long‐term antibiotic therapy (2001) (46)
- Diagnosis and management of Skin and Soft-Tissue Infections (SSTI): a Literature Review and Consensus Statement on Behalf of the Italian Society of Infectious Diseases and International Society of Chemotherapy (2011) (46)
- Epidemiology and management of candidaemia – a retrospective, multicentre study in five hospitals in the UK (2011) (44)
- Identification and characterization of teicoplanin-intermediate Staphylococcus aureus blood culture isolates in NE Scotland. (2002) (43)
- Relationship between the number of different antibiotics used and the total use of antibiotics in European hospitals. (2006) (42)
- Antibiotics, skin and soft tissue infection and meticillin-resistant Staphylococcus aureus: cause and effect. (2009) (40)
- Coping with antibiotic resistance: the impending crisis. (2010) (39)
- The role of microbiology and pharmacy departments in the stewardship of antibiotic prescribing in European hospitals. (2007) (39)
- Toxocariasis and eosinophilic meningitis. (1985) (38)
- Trends in hospital antimicrobial prescribing after 9 years of stewardship. (2000) (38)
- Are There Regional Variations in the Diagnosis, Surveillance, and Control of Methicillin-Resistant Staphylococcus aureus? (2003) (38)
- Staphylococcus aureus carriage among participants at the 13th European Congress of Clinical Microbiology and Infectious Diseases (2005) (37)
- Susceptibility to chlorhexidine amongst multidrug-resistant clinical isolates of Staphylococcus epidermidis from bloodstream infections. (2016) (37)
- PSEUDOMONAS AERUGINOSA: CLINICAL MANIFESTATIONS AND MANAGEMENT (1985) (37)
- Antimicrobial Agents are Societal Drugs (2012) (36)
- Quinolone resistant Haemophilus influenzae. (1994) (36)
- Effects of Storage on Vancomycin and Daptomycin MIC in Susceptible Blood Isolates of Methicillin-Resistant Staphylococcus aureus (2012) (36)
- Trimethoprim resistance plasmids in faecal bacteria (1984) (36)
- Clinical activity of anti-Gram-positive agents against methicillin-resistant Staphylococcus aureus. (2011) (35)
- Comparison of screening methods for TEM- and SHV-derived extended-spectrum beta-lactamase detection. (2002) (35)
- Maximizing the impact of antimicrobial stewardship: the role of diagnostics, national and international efforts (2013) (34)
- Control of antibiotic use in the United Kingdom. (1988) (33)
- The problem with glycopeptides. (2007) (32)
- In-vitro pharmacodynamic studies of piperacillin/tazobactam with gentamicin and ciprofloxacin. (1997) (31)
- Postantibiotic effect of meropenem on members of the family Enterobacteriaceae determined by five methods (1994) (31)
- Community-acquired MRSA: can we control it? (2006) (31)
- Sequential antibiotic therapy for cost containment in the hospital setting: why not? (2001) (31)
- Stewardship of antibiotic use and resistance surveillance: the international scene. (1999) (29)
- Optimizing antibiotic therapy-the Aberdeen experience. (2003) (29)
- Phenoxymethyl penicillin versus co-amoxiclav in the treatment of acute streptococcal pharyngitis, and the role of beta-lactamase activity in saliva. (1996) (29)
- Comparison of methodologies used in assessing the postantibiotic effect. (1994) (29)
- Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA (2017) (28)
- Use of the Malthus Microbial Growth Analyser to study the post antibiotic effect of antibiotics. (1989) (27)
- Phylogenetic analysis of resistance to ceftazidime/avibactam, ceftolozane/tazobactam and carbapenems in piperacillin/tazobactam-resistant Pseudomonas aeruginosa from cystic fibrosis patients. (2019) (26)
- Epidemiology of infection due to Escherichia coli O157: a 3-year prospective study (1996) (26)
- Penetration of amoxycillin/clavulanic acid into bronchial mucosa with different dosing regimens. (1994) (26)
- Global Antibiotics Use and Resistance (2020) (25)
- Antibiotic policies : fighting resistance (2008) (25)
- Systematic review of antimicrobial drug prescribing in hospitals. (2006) (24)
- Antibiograms of resistant Gram-negative bacteria from Scottish CF patients. (2004) (23)
- Report of a hospital neonatal unit outbreak of community-associated methicillin-resistant Staphylococcus aureus (2009) (23)
- Interaction of imipenem with erythromycin and tetracycline assessed by microdilution checkerboard techniques (1991) (23)
- Ionic binding, adaptive resistance and post-antibiotic effect of netilmicin and ciprofloxacin. (1991) (23)
- Antibiotic use and resistance in hospitals: time-series analysis strategy for determining and prioritising interventions (2020) (23)
- Brief report: Respiratory tract penetration of ciprofloxacin (1989) (23)
- Prevention of endocarditis: communication between doctors and dentists (1992) (22)
- Antibiotic stewardship: prescribing social norms (2016) (22)
- Temporal relationship between prevalence of meticillin-resistant Staphylococcus aureus (MRSA) in one hospital and prevalence of MRSA in the surrounding community: a time-series analysis. (2007) (22)
- Controversies in infection: infection control or antibiotic stewardship to control healthcare-acquired infection? (2009) (21)
- Treatment options for methicillin-resistant Staphylococcus aureus (MRSA) infection: Where are we now? (2014) (21)
- Role of old antimicrobial agents in the management of urinary tract infection (2016) (21)
- Empirical antimicrobial treatment for chemotherapy-induced febrile neutropenia. (2007) (21)
- Concentration-dependent bacterial killing, adaptive resistance and post-antibiotic effect of ciprofloxacin alone and in combination with gentamicin. (1990) (21)
- Risk factors for acquisition of multiply drug-resistant gram-negative bacteria (2006) (21)
- Control of methicillin-resistant Staphylococcus aureus in the UK (2005) (20)
- Impacts of a long-term programme of active surveillance and chlorhexidine baths on the clinical and molecular epidemiology of meticillin-resistant Staphylococcus aureus (MRSA) in an Intensive Care Unit in Scotland. (2012) (19)
- Is vancomycin redundant for serious staphylococcal infection? (2010) (18)
- Classification of oral cephalosporins. A matter for debate. (2001) (18)
- High dose oral fluconazole for oropharyngeal candidosis in AIDS. (1990) (17)
- Chemoprophylaxis for bacterial endocarditis--a survey of current practice in London. (1984) (17)
- Extended spectrum -lactamases (1998) (17)
- Optimization of antibiotic dosing schedules in the light of increasing antibiotic resistance (2004) (16)
- Antibiotic policies in Central/Eastern Europe (CEE) after 1990. (1999) (16)
- Antimicrobial susceptibility testing in European hospitals: report from the ARPAC study. (2006) (16)
- Food poisoning due to the consumption of red whelks (Neptunea antiqua) (1988) (16)
- Multiply-resistant Klebsiella pneumoniae: failure of spread in community-based elderly care facilities. (1998) (16)
- Piperacillin/tazobactam in the treatment of serious acute soft tissue infection. (1991) (16)
- Endogenous bacterial contamination of enteral tube feeding systems during administration of feeds to hospital patients (1995) (15)
- Quantitative Measurement of Antibiotic Use (2005) (15)
- A Retrospective Cohort Study into Acquisition of MRSA and Associated Risk Factors after Implementation of Universal Screening in Scottish Hospitals (2011) (14)
- Towards a European strategy for controlling antibiotic resistance Nijmegen, Holland August 29-31, 1999. (2000) (14)
- Amoxycillin/clavulanic acid levels in lower respiratory secretions. (1988) (14)
- The effect of system design on bacterial contamination of enteral tube feeds. (2001) (14)
- Challenges and opportunities for antimicrobial stewardship in resource-rich and resource-limited countries (2019) (13)
- Antimicrobials: an endangered species? (2007) (13)
- Novel plate culture method to improve the microbiological diagnosis of peritonitis in patients on continuous ambulatory peritoneal dialysis (1988) (13)
- Vancomycin in the treatment of meticillin-resistant Staphylococcus aureus (MRSA) infection: End of an era? (2013) (13)
- The Lancet Infectious Diseases Commission Antibiotic resistance—the need for global solutions (2013) (13)
- Fighting MRSA in hospitals: time to restrict the broad use of specific antimicrobial classes? (2005) (12)
- Towards a common susceptibility testing method? (2000) (12)
- Combination antimicrobial susceptibility testing of Burkholderia cepacia complex: significance of species. (2016) (12)
- Accelerated bacteriological evaluation in the management of lower respiratory tract infection in general practice. (1997) (11)
- An update on Staphylococcus aureus infective endocarditis from the International Society of Antimicrobial Chemotherapy (ISAC). (2019) (11)
- Current prophylaxis for prevention of infective endocarditis (1990) (11)
- Corynebacterium afermentans subsp. lipophilum: multiple abscess formation in brain and liver. (1995) (10)
- Assessment of the efficacy, safety and quality of gentamicin use in Aberdeen Royal Infirmary. (1999) (10)
- The high vaginal swab in general practice: clinical correlates of possible pathogens. (1995) (10)
- Determinants of response to antibiotic therapy. (1998) (10)
- Antibacterials in the pipeline and perspectives for the near future. (2019) (10)
- In-vitro bacterial killing kinetics of ticarcillin/clavulanic acid. (1987) (10)
- Methicillin-Resistant Staphylococcus aureus in Northeastern Scotland in 2003 to 2007: Evolving Strain Distribution and Resistance Patterns (2011) (10)
- An unusual case of Corynebacterium striatum endocarditis and a review of the literature. (2008) (10)
- Dissecting a multi-intervention methicillin-resistant Staphylococcus aureus prevention bundle may miss emergent properties. (2012) (9)
- Antibiotic resistance: understanding how to control it. (2012) (9)
- Questions about the 10 x '20 Initiative. (2010) (9)
- Ampicillin, Amoxicillin and Other Ampicillin-Like Penicillins (2010) (9)
- Automatic procedures for measuring post-antibiotic effect and determining random errors. (1994) (9)
- An open study of teicoplanin in the treatment of gram-positive infections. (1991) (8)
- Reduced penicillin susceptibility of group B Streptococcus: an assessment of emergence in Grampian, Scotland (2016) (8)
- National and Local Antibiotic Policies in Central and Eastern Europe (2000) (8)
- Antibiotic exposure as a risk factor for emergence of resistance: the influence of concentration. (2002) (8)
- A cross‐sectional survey of antimicrobial stewardship strategies in UK hospitals (2014) (8)
- Do we need fourth-generation cephalosporins? (1999) (8)
- Antibiotics for surgical patients: the faster the better? (2012) (7)
- Time for biocide stewardship? (2019) (7)
- Severe Salmonellosis Related to Oral Administration of Anti-Diarrhoeal Drugs (1990) (7)
- Audit of an antibiotic policy and microbiological investigations for treating bacteraemia in a large teaching hospital. (2003) (7)
- Listeria monocytogenes and Staphylococcus aureus coinfection of a prosthetic joint. (2008) (7)
- Systematic review of the effectiveness of preventing and treating Staphylococcus aureus carriage in reducing peritoneal catheter-related infections. (2007) (7)
- Vancomycin minimum inhibitory concentrations and outcome in patients with severe Staphylococcus aureus infection. (2012) (7)
- Comparative healthcare-associated costs of methicillin-resistant Staphylococcus aureus bacteraemia-infective endocarditis treated with either daptomycin or vancomycin. (2016) (7)
- Does vancomycin have a future in the treatment of skin infections? (2014) (7)
- Two cases of disseminated toxocariasis in compromised hosts successfully treated with mebendazole. (1992) (7)
- Antibiotic Use and Development of Resistance in Blood Culture Isolates: 8 Years of Experience from a Cancer Referral Center (2001) (7)
- Prevention of Haematogenous Infection in Prosthetic Joints (1988) (6)
- Longitudinal Surveillance and Combination Antimicrobial Susceptibility Testing of Multidrug-Resistant Achromobacter Species from Cystic Fibrosis Patients (2020) (6)
- BTS guidelines on CAP (2002) (6)
- Genomic Stability of Composite SCCmec ACME and COMER-Like Genetic Elements in Staphylococcus epidermidis Correlates With Rate of Excision (2020) (6)
- Antimicrobial Synergy Testing: Comparing the Tobramycin and Ceftazidime Gradient Diffusion Methodology Used in Assessing Synergy in Cystic Fibrosis-Derived Multidrug-Resistant Pseudomonas aeruginosa (2021) (6)
- MRSA In Practice (2006) (6)
- The post-exposure response of Enterobacteriaceae to ceftibuten. (1999) (6)
- Surveillance of Antibiotic Resistance in Developing Countries: Needs, Constraints and Realities (2010) (6)
- Imipenem versus standard therapy in the treatment of serious soft tissue infection. (1988) (5)
- Using Daptomycin in Hospitalised Patients with cSSTI Caused by Staphylococcus aureus Has an Impact on Costs (2014) (5)
- Pharmacodynamics and the relationship between in vitro and in vivo activity of antimicrobial agents. (1997) (5)
- Attitudes to antibiotic prescribing, resistance and bacteriology investigations amongst practitioners and patients in the Grampian region of Scotland (2007) (5)
- Molecular epidemiology and antibiotic resistance of Enterobacter spp. from three distinct populations in Grampian, UK. (2002) (5)
- Penicillin-resistant pneumococcal meningitis (1992) (5)
- Third generation cephalosporins. (1985) (5)
- Over-the-counter availability of antibiotics. (1996) (4)
- MDRO Beijing Consensus Meeting Report: Global burden of multidrug-resistant organisms' current antimicrobial resistance problems in Asia-Pacific. (2014) (4)
- Antibiotic resistance in nosocomial isolates in Scotland. (1996) (4)
- Reassessment of the cefaclor breakpoint for Streptococcus pneumoniae. (2004) (4)
- Benefits of antimicrobial stewardship in hospitals: Evidence from a recent Cochrane review (2015) (4)
- For debate The response of Enterobacteriaceae to -lactam antibiotics —'round forms, filaments and the root of all evil' (1997) (4)
- Calculation of composite recovery time: a new pharmacodynamic parameter. (2002) (4)
- Infection services in the intensive care unit. (2000) (4)
- Duration of intravenous therapy and hospital stay according to choice of empirical antimicrobial treatment for community-acquired respiratory infection. (1999) (4)
- Respiratory tract penetration of ciprofloxacin. (1989) (4)
- Prevention of infective endocarditis (1988) (4)
- Impact of hypochlorite disinfection on meticillin-resistant Staphylococcus aureus rate. (2011) (4)
- Measurement of Antibiotic Efficacy – Beyond the MIC (2001) (3)
- Decision and cost analysis of empirical antibiotic therapy of acute sinusitis in the era of increasing antimicrobial resistance: do we have an additional tool for antibiotic policy decisions? (2017) (3)
- The resistance profile of Acinetobacter baumannii strains isolated from the Aberdeen Royal Infirmary. (2012) (3)
- Antibiotic Stewardship: What's Not To Like? (2016) (3)
- Introduction: Antibiotic Prophylaxis in Clean Surgery (2001) (3)
- Can We Control MRSA? (2007) (3)
- Comment on: Interventions to control MRSA: high time for time-series analysis? (2008) (2)
- O23 Impact of hypochlorite disinfection on MRSA rates (2007) (2)
- The two Alexanders (Gordon and Ogston): Aberdeen's early contribution to the understanding of infection control. (2008) (2)
- Antibiotic Use—Ecological Issues and Required Actions (2005) (2)
- Use of active surveillance cultures in intensive care units. (2009) (2)
- Skin and soft tissue infections. Introduction. (2009) (2)
- Act now on antibiotic resistance (1998) (2)
- Trends of Antimicrobial Resistance and Combination Susceptibility Testing of Multidrug-Resistant Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients: a 10-Year Update (2021) (2)
- Frontiers in Antimicrobial Resistance: A Tribute to Stuart B. LevyDavid G. White, Michael N. Alekshun andPatrick F. Mcdermott, Eds.ASM Press, USA, 2005.ISBN 1-55581-329-1. $119.95, 598 pp. (2006) (2)
- Comment on: 'Antibiotic footprint' as a communication tool to aid reduction of antibiotic consumption. (2019) (2)
- Trimethoprim resistance plasmids. (1984) (2)
- Who's winning the war? (2008) (2)
- A Scottish history for today (1966) (2)
- MRSA bacteraemia. (2007) (2)
- BTS guidelines on CAP. Community acquired pneumonia. (2002) (2)
- Eff ects of national antibiotic stewardship and infection control strategies on hospital-associated and community-associated meticillin-resistant Staphylococcus aureus infections across a region of Scotland : a non-linear time-series study (2015) (2)
- Benzylpenicillin (penicillin G) (2017) (2)
- Are all Staphylococcus aureus equal? (2015) (2)
- Diagnosis of bacterial vaginosis in a routine diagnostic laboratory. (1992) (2)
- Hospital Antibiotic Stewardship to Control Resistance—How Should It be Done? (2012) (1)
- Reassessment of Cefaclor Breakpoints for Haemophilus influenzae (2004) (1)
- P29.24 The value of nasal swabs, multiple body site screening and clinical risk assessment to detect MRSA colonisation in pathfinder hospitals in Scotland (2010) (1)
- Trends of antimicrobial resistance and combination susceptibility testing of cystic fibrosis multidrug-resistant Pseudomonas aeruginosa: A ten-year update. (2021) (1)
- The Significance of Fever and Increased Erythrocyte Sedimentation Rate Occurring in Patients in A General Medical Unit (1983) (1)
- Septic arthritis caused by slow-growing gram negative bacillus cat in the act? (1998) (1)
- The Antibiotic Paradox (2012) (1)
- Combination testing of colistin with telavancin and daptomycin. (2014) (1)
- 'The Chennai declaration': India co-ordinates action against antimicrobial resistance. (2013) (1)
- SP29-3 Using time series analysis for surveillance of resistance and antimicrobial use. The ViResiST project (2013) (1)
- Comment on: Lack of upward creep of glycopeptide MICs for methicillin-resistant Staphylococcus aureus (MRSA) isolated in the UK and Ireland 2001-07. (2013) (1)
- Controlling hospital MRSA (2013) (1)
- 12th International Congress of Chemo-therapy Florence—19–24 July 1981 (1982) (1)
- Cryptosporidiosis in Grampian 1988-1993 (1996) (1)
- The effects of the morphological response of Enterobacteriaceae to cephalosporins on PAE and CERT. (1998) (1)
- Teicoplanin for prophylaxis of endocarditis after dental bacteraemia. (1990) (1)
- Ofloxacin-developments in therapy; based on contribution to the Third International Symposium on Ofloxacin, sponsored by Hoechst, FRG, held in Scheveningen, the Netherlands, 26-27 April 1990. (1990) (1)
- Antibiotic policies in European hospitals. (2005) (1)
- Cost effectiveness of dipsticks. (1991) (1)
- Combination antimicrobial susceptibility testing of multidrug-1 resistant Stenotrophomonas maltophilia in cystic fibrosis 2 3 (0)
- Comprar Antibiotic Policies: | Gould, Ian M. | 9781441917331 | Springer (2011) (0)
- Genomic stability of composite SCCmec COMER-like and ACME genetic elements in Staphylococcus epidermidis correlates with rate of excision (2020) (0)
- Ampicillin and amoxicillin (2017) (0)
- P29.25 Development of a clinical risk assessment tool to predict MRSA colonisation on admission to hospital (2010) (0)
- Selective parenteral and enteral antisepsis regimen (SPEAR). (1990) (0)
- Measures to prevent antimicrobial resistance (2013) (0)
- Mesalazine preparations (1998) (0)
- Chlorhexidine Resistance or Cross-Resistance, That Is the Question (2023) (0)
- A new Scottish history (1980) (0)
- Interaction ofImipenem withErythromycin andTetracycline Assessed byMicrodilution Checkerboard Techniques (1991) (0)
- SP8-2 MRSA infections – a clinical challenge for treatment and prevention (2013) (0)
- Penicillin-resistant pneumococcal meningitis. (1992) (0)
- Improving the antibiotic pipeline (2008) (0)
- Antibiotic prophylaxis and endocarditis (1992) (0)
- A non-linear time-series analysis approach to identify thresholds in 1 associations between population antibiotic use and rates of resistance 2 3 (2019) (0)
- A nonlinear time-series analysis approach to identify thresholds in associations between population antibiotic use and rates of resistance (2019) (0)
- Old forgotten antibiotics: Do we need them?: Category: Scientific free paper (2011) (0)
- Antibiotic prophylaxis and endocarditis. Author's reply (1992) (0)
- SY.7.2 MIC CREEP: DOES IT EXIST? (2013) (0)
- Community-acquired pneumonia. (2015) (0)
- KS10-1 Nobel laureates and antimicrobial chemotherapy (2013) (0)
- Safety and efficacy of gentamicin therapy (1999) (0)
- Special Issue: New issues in skin and soft tissue infections. (2009) (0)
- Pooled versus individual nucleic acid amplification testing for detection of active SARS-CoV-2 infection (Protocol) (2020) (0)
- Co-infection d'une prothèse articulaire par Listeria monocytogenes et le Staphylocoque doré (2008) (0)
- Penicillin-resistant pneumococcal meningitis. Author's reply (1992) (0)
- Fusidic acid (2021) (0)
- Ototoxicity caused by aminoglycosides- A neonatal perspective (2017) (0)
- WITHDRAWN: Antibiotic Stewardship and Use in European Arpac Hospitals (2006) (0)
- Epidemic Diseases in Aberdeen and the History of the City Hospital (2002) (0)
- Optimizing Antimicrobial Chemotherapy in the ICU—A Review (2008) (0)
- CO-AMOXICLAV LEVELS IN BRONCHIAL MUCOSA. AUTHORS' REPLY (1995) (0)
- The Intelligent Microbe, Jean-Claude Pechère. Frison-Roche, Paris (2007), ISBN: 978-2-87671-507-3 (2007) (0)
- Comparison of the E test with broth microdilution for antifungal susceptibility testing of yeasts. (1998) (0)
- For debate Towards a common susceptibility testing method (2000) (0)
- Keynote sessions and SymposiaSaturday, 8th June 2013Symposium 36. Endocarditis: novel aspectsSP36-2 MIC Creep: Does it exist? (2013) (0)
- Developing resistance to drugs against MRSA (2012) (0)
- Bts Guidelines on Cap Transudates and Exudates Authors' Reply (0)
- Author Correction: A nonlinear time-series analysis approach to identify thresholds in associations between population antibiotic use and rates of resistance (2020) (0)
- New quinolones in clinical practice. (1999) (0)
- 47 Diagnostic dilemmas for CF microbiology labs using MALDI-TOF (2015) (0)
- Current challenges in treating methicillin-resistantStaphylococcus aureus: what are the options? (2013) (0)
- Questions linked to Gould IM. The clinical significance of methicillin‐resistant Staphylococcus aureus. J Hosp Infect 2005;61:277–282. (2006) (0)
- Controlling multi-drug resistance (2015) (0)
- Nitrofurantoin (2022) (0)
- NovelPlate Culture MethodToImprovetheMicrobiological Diagnosis ofPeritonitis inPatients on Continuous Ambulatory Peritoneal Dialysis (1988) (0)
- Transfusion-transmitted malaria: is hope around the corner? (2016) (0)
- Antimicrobial practice Antibiotic use in Dutch hospitals 1991–1996 (2000) (0)
- Time for biocide stewardship? (2019) (0)
- FP2.1 Universal screening for MRSA: Results from a multicentre evaluation across 6 hospitals in Scotland (2010) (0)
- Amoxycillin/clavulanic acid levels in respiratory secretions. (1989) (0)
- Molecular characterization of Methicillin-resistant Staphylococcus aureus from intensive care unit in Aberdeen Royal Infirmary, Scotland : Category: Lesson in Microbiology & Infection Control (2011) (0)
- Innovations in Antimicrobial Stewardship (2018) (0)
- Grampian region of Scotland to evaluate the use of accelerated bacteriological examination (ABLE) of sputum samples as a guide to the use of antibiotics for the treatment of bronchitis (2005) (0)
- Antimicrobial Prophylaxis in the Intensive Care Unit (2007) (0)
- Contents Vol. 59, 2013 (2014) (0)
- AUTHORS' REPLY (1995) (0)
- Systematic Review and Network Meta-Analysis of Tedizolid for the treatment of acute Bacterial Skin and Skin Structure Infection (Absssi) Due to Methicillin-Resistant Staphylococcus Aureus (Mrsa) (2015) (0)
- P1589 Report of a hospital outbreak of CA-MRSA (2007) (0)
This paper list is powered by the following services:
